Naperville, IL -- (SBWIRE) -- 02/04/2015 -- Reportstack, provider of premium market research reports announces the addition of Global Migraine Drugs Market 2015-2019 market report to its offering.
"[This report is Upcoming for publication on February 04,2015. However you can Pre-order this report.]"
About Migraine
Migraine is a complex neurological medical condition characterized by a severe headache. The headache is often accompanied by nausea, vomiting, and extreme sensitivity to light and sound. Given their hormonal fluctuation, women are more susceptible to have migraine than men. Anti-migraine drugs are the therapeutic agents to be used against migraine. Treatment includes painkillers, anti-inflammatory painkillers, anti-sickness medicines, and triptan medicines.
Analysts forecast the Global Migraine Drugs market to grow at a CAGR of 3.54 percent over the period 2014-2019.
Covered in this Report
The report covers the present scenario and the growth prospects of the Global Migraine Drugs market for the period 2015–2019. The Global Migraine Drugs market can be divided into two segments: Selective Serotonin Receptor (5- HTI) Agonists/ Triptans and Ergot Alkaloids. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment and prevention of migraine that are available in the market.
Global Migraine Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC region, and the EMEA region; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
- Americas
- APAC
- EMEA
Key Vendors
- Abbott
- Allergan
- Eisai
- Endo
- GlaxoSmithKline
- Impax Laboratories
- Pfizer
Other Prominent Vendors
- Almirall
- Amgen
- AstraZeneca
- Boehringer Ingelheim
- Eli Lilly
- IntelGenx Technologies
- Johnson & Johnson
- Nautilus
- OptiNose
- RedHill Biopharma
- Zogenix
Market Driver
- Increase in Prevalence of Migraine
- For a full, detailed list, view our report
Market Challenge
- High Cost of Drugs
- For a full, detailed list, view our report
Market Trend
- Increase in Strategic Collaborations
- For a full, detailed list, view our report
Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Complete report is available @
http://www.reportstack.com/product/191378/global-migraine-drugs-market-2015-2019.html
Contact:
Roger Campbell
roger@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604